Endometriosis: medical therapy

Area of Science:

• Gynecology
• Reproductive Medicine
• Medical Research

Background:

• Endometriosis management is complex, requiring individualized patient care.
• Common medical therapies include danazol, GnRH agonists, medroxyprogesterone acetate, and gestrinone, showing similar efficacy but with side effects limiting long-term use.
• Hormone replacement therapy with GnRH agonists may allow prolonged use, but cost is a barrier.

Purpose of the Study:

• To review current medical management strategies for endometriosis.
• To evaluate the efficacy and limitations of existing treatments.
• To identify areas for future research in endometriosis therapy.

Main Methods:

• Review of existing studies on medical therapies for endometriosis.
• Analysis of treatment efficacy based on laparoscopic scores and symptom relief.
• Evaluation of treatment roles in endometriosis-associated infertility.

Main Results:

• Established medical therapies (danazol, GnRH agonists, etc.) demonstrate equal efficacy in reducing disease severity and symptoms.
• Adverse effects of current treatments restrict their long-term application.
• Hormonal therapy is not recommended for early-stage (I-II) endometriosis with infertility; surgery is preferred for advanced stages (III-IV).
• In vitro fertilization and embryo transfer are effective for infertility, potentially optimized by prior medical therapy.

Conclusions:

• Despite advances, current medical treatments for endometriosis are not curative.
• Low-dose oral contraceptive pills warrant further investigation for prolonged use.
• Novel therapeutic approaches are essential for the definitive eradication of endometriosis.